Table 5 Multivariate Cox regression for DFS in the prospective study.

From: Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy

Variables

Prospective cohort study

B

HR(95% CI)

P

Pathological response

 OPR

 

1

 

 Non-OPR

1.39

4.03(0.98,16.52)

0.053

Age

 ≤44 years

 

1

 

 >44

0.89

2.43(1.44,4.13)

0.001

Lymph node metastasis

 Negative

 

1

 

 Positive

0.43

1.54(1.01,2.36)

0.045

  1. DFS, disease free survival.